Category JPND News

To all PIs and coordinators currently running ERA-Net NEURON and JPND projects, ERA-Net Neuron is offering 5 vacant places to an Open Science and Responsible Research Innovation (RRI) workshop in Berlin. Registration deadline: November 30th 2025. Find out more and…

  Fellowships United States of America Parkinson’s disease & PD-related disorders 2016

The European Joint Programming Initiative on Neurodegenerative Disease Research (JPND) launches its highly anticipated International Scientific Meeting Leading researchers from 30 JPND supported projects on neurodegenerative disease research will gather in Brussels on the 28th April 2022, for the JPND[1] /JPco-fuND…

The EU-funded European Brain Research Area project today releases its long-awaited European Research Inventory and Mapping Report, providing insight into the brain research activities funded at the European level within the EU framework programmes FP7 and Horizon 2020, as well…

On 27 th May 2021, JPND held a virtual workshop at the annual Dementia Forum X where participants gathered ideas and insights from the world’s leading researchers, policy makers and stakeholders in the field of dementia. Titled Patient and Public…

  A CALL FOR LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS TO NEURODEGENERATIVE DISEASES The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has announced an €19 million transnational call for multinational research on linking pre-diagnosis disturbances of physiological systems…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a new multinational call for proposals for “Linking pre-diagnosis disturbances of physiological systems to Neurodegenerative Diseases”. The development of efficient treatments for most neurodegenerative disease is hindered by the…

The EU Joint Programme on Neurodegenerative Disease Research (JPND) has awarded funding to twelve multi-national research teams in order to enable research projects on Novel Imaging and Brain Stimulation Methods and Technologies, that may in time bring about the delivery of…

A CALL FOR NOVEL IMAGING AND BRIAN STIMULATION METHODS AND TECHNOLOGIES RELATED TO NEURODEGENERATIVE DISEASES The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has announced an €18 million transnational call for multinational research on novel imaging and brain…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a new multinational call for proposals for “Novel imaging and brain stimulation methods and technologies related to Neurodegenerative Diseases”. Recent years have seen major increases in the range and…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative[1] has launched its updated global Research and Innovation Strategy (RIS), to provide a unified framework for the support of world class research into neurodegenerative diseases. Neurodegenerative diseases are one of…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on personalised medicine for neurodegenerative diseases. Neurodegenerative diseases are debilitating and still largely untreatable conditions. These diseases are characterised by a…

Launched on 1 November 2018, the European Brain Council (EBC)-coordinated EU project The European Brain Research Area (EBRA), was designed to respond to the Horizon 2020 call SC1-HCO-10-2018, entitled ‘Coordinating European brain research and developing global initiatives’. Aimed at reducing…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a new cohesive action with the European Commission – a call for “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”. More than €30 million have already been earmarked…

The EU Joint Programme on Neurodegenerative Disease Research (JPND) has awarded funding to ten multi-national research teams in order to increase understanding of the factors that contribute to the quality and delivery of health and social care for neurodegenerative diseases. Current…

Did you know that there are 10 JPIs (Joint Programming Initiatives) addressing societal challenges, from climate change to neurodegenerative diseases, through coordinated research and innovation in Europe? Watch the video below, created in honour of the tenth anniversary of JPIs,…

From today, funders and researchers can access a database containing survey information spanning three decades-worth of global neurodegenerative disease research funding. The new, expanded online database is the result of a large-scale mapping exercise of neurodegenerative disease research investments and…

Two major research funding entities in the EU and US are joining forces for the first time to optimise and harmonise research into neurodegenerative diseases. The EU Joint Programme on Neurodegenerative Disease Research (JPND) and the U.S. National Institute on…

JPND’s database of experimental models for Parkinson’s disease has recently been updated with 29 additional new pages on in-vivo mammalian models. The database,  which was first made available to the community in 2017, is a unique collection aimed at presenting…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) has awarded funding to ten research projects to perform new network analyses in order to better understand the common underlying mechanisms involved in neurodegenerative diseases. Previous research has already shown that…

The UK Dementia Research Institute (UK DRI) is now recruiting an associate director to lead its care and technology programme. Candidates should have an exciting vision for how patient-focused research can lead to a significantly improved quality of life for people…

The U.S. Alzheimer’s Association is now accepting letters of intent (LOI) for a new programme called GAAIN Exploration to Evaluate Novel Alzheimer’s Queries (GEENA-Q). The Global Alzheimer’s Association Interactive Network (GAAIN) is a big data platform for cohort discovery and…

How should academia and industry collaborate to generate new diagnostic tools and therapies for neurodegenerative diseases? At a workshop in Turin in October 2017, JPND brought together some 20 representatives from academia and the private sector to address this question…

To mark the end of the FlySMALS consortium, which was funded in the 2013 JPND Cross-Disease Analysis call, project partners are now organising a workshop on integrative approaches in neurodegeneration. The workshop, which will take place in Lisbon, Portugal, from…

The Weston Brain Institute is now accepting applications to its Rapid Response: Ireland, Netherlands, UK 2018 (Fluid Biomarkers) program. This initiative aims to provide seed funding, without requirement for preliminary data, to support high-risk, high-reward, translational research on novel biomarkers…

The International Consortium for Personalised Medicine, ICPerMed, is now accepting applications to its inaugural “Best Practice in Personalised Medicine” award. Created with the aim of encouraging and disseminating examples of best practices in personalised medicine (PM), the award is open…

To mark the half-way point of the three-year projects funded in 2015 for the JPco-fuND call, the project coordinators of the 21 projects met for a two-day symposium in The Hague to learn about each other’s work, strengthen existing ties…

Principal investigators representing 21 projects JPND projects will be gathering tomorrow to meet, network and  participate in panel discussions in order to learn about each other’s work and increase their collaborations so as to fight neurodegenerative diseases even more efficiently.…

The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a call for “Multinational research projects on Health and Social Care for Neurodegenerative Diseases”. There are an estimated 47 million people suffering from Alzheimer’s disease and related disorders worldwide.…

Researchers studying neurodegenerative disease can now look up cohort studies and make connections through a new online database. The JPND Global Cohort Portal, created by the EU Joint Programme – Neurodegenerative Disease Research (JPND), is a searchable online database of…

A new, publicly accessible website is cataloguing the range of animal and cellular models currently available for the study of Parkinson’s disease (PD) and providing a forum for scientists to discuss the limitations of these models and how they might…

The Joint Programming initiative on Neurodegenerative Diseases research aims to begin a dialogue with companies active in the neurodegenerative disease field, including imaging, diagnostics, IT, medical devices and more. This dialogue will foster collaboration and help JPND orient its research…

Many longitudinal cohort studies exist across Europe that hold the kind of data that would help researchers better understand the development and progression of neurodegenerative diseases. To help researchers get the most out of this cohort data, JPND funded ten…

For Public to Public Partnerships (P2Ps), impact assessment is an important objective, as underscored by the attendees of the Annual Joint Programming Conference of 2016. To that end, adequate Monitoring and Evaluation processes must be developed and implemented. JPND’s 2016-2017…

The EU Joint Programme – Neurodegenerative Disease Research (JPND), will host a half-day workshop led by the Italian Ministry of Education, Universities and Research (MIUR) from 9 a.m. to 1 p.m. on October 12, 2017, focused on fostering cooperation in…

Introducing the first global database of cohorts for neurodegenerative diseases To promote the use and connection of cohort studies, the Joint Programme for Neurodegenerative Disease Research (JPND) has developed a new online gateway to longitudinal cohorts suitable for neurodegenerative disease…

Prof. Philippe Amouyel, Chair of the JPND Management Board, discusses JPND progress and priorities for the future in issue one of Pan European Networks: Health. In the interview, Prof. Amouyel outlines some of JPND’s major recent and future developments and…

The trio of Presidencies of the Council of the European Union 2016-2017 (the Netherlands, Slovakia and Malta) have signed a Joint Statement on Dementia, issued during the meeting of the governmental expert group on dementia in Malta on May 15-16,…

The OECD has published a new report summarising the second Lausanne Workshop on “Global Action to Drive Innovation in Alzheimer’s disease and other Dementias – Connecting Research, Regulation and Access.” The workshop was held on 15-16 December 2015 in Lausanne,…

In concert with the Slovak Presidency of the Council of the European Union, two leading health research scientists from the Slovak Republic, which is a member of JPND, presented their work during the meeting of the Research Working Party in…

  For more than 20 years, the Meeting Centres Support Programme has been offering people in the Netherlands who are living with dementia and their family carers specially designed support as they adapt to life with dementia. Developed by Professor…

In light of the United Kingdom’s 2016 referendum on membership to the European Union, the Medical Research Council (MRC), which represents the UK at the JPND Management Board, affirms that it will continue to pursue a collaborative, international research agenda…

At a recent meeting in Amsterdam, members of the JPND Management Board, which is the decision-making body of JPND, were invited to tour Reigershoeve, a patient-centered residential ‘care farm’ for people living with dementia. Located in Heemskerk, about a half…

The Lancet Neurology Conference: Preclinical neurodegenerative disease — towards prevention and early diagnosis is now accepting abstracts for poster presentation at its 2016 meeting, which will take place October 19-21, 2016, in London, UK. Abstracts can be submitted on the…

Today the Lancet Neurology Commission released a major report detailing the state of research and patient care for Alzheimer´s disease and other dementias and providing recommendations for the future. The conclusion: A concerted effort and long-term economic commitment are critical…

The Active and Assisted Living Programme (AAL), which aims to improve the conditions of life for older adults through the use information and communication technology (ICT), has opened its 2016 call, Living well with dementia. The objective of the call…

Alzheimer Europe and Alzheimerforeningen are now accepting abstracts for the 26th Alzheimer Europe Conference, which will take place from October 31 – November 2, 2016, in Copenhagen, Denmark. Abstracts for oral and poster presentations can be submitted in the following…

The European Medicines Agency (EMA) has released draft revised guidelines on medicines for the treatment of Alzheimer’s disease and other types of dementias for a six-month public consultation. EMA follows a multi-stakeholder approach to facilitate research and development of more…

The ERA-NET NEURON has launched a new call for research proposals that will aim to address key questions relating to external insults to the central nervous system. These insults often cause permanent disability and constitute a heavy burden for patients…

The Innovative Medicines Initiative (IMI) has launched a new call for research proposals that will aim to accelerate the development of medicines in a number of key areas, including neurological disorders. The Alzheimer’s disease and Parkinson’s disease topic of the…